AffaMed announces dosing of first subject in retinal disease therapy trial
AffaMed Therapeutics has announced dosing of the first subject in the Phase I clinical trial of AM712 to treat retinal diseases in the US.
Source: clinicaltrialsarena.com
Page 5 - Centric Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Centric Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Centric Services Today - Breaking & Trending Today
Kintara activates first European site of Phase II/III glioblastoma trial
Kintara Therapeutics has activated the first European site of the VAL-083 treatment arm in the Phase II/III trial for treating glioblastoma.
Source: clinicaltrialsarena.com
Corcept terminates Phase III pancreatic ductal adenocarcinoma trial
Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.
Source: clinicaltrialsarena.com
Humanetics extends long COVID drug trial to more sites
Humanetics has expanded clinical trial of a new oral drug, BIO 300, for long-haul Covid-19 (long COVID) to include two more US study sites.
Source: clinicaltrialsarena.com
Moderna, IAVI to commence trial of mRNA HIV vaccine trial in Africa
Moderna and IAVI are set to commence Phase I IAVI G003 clinical trial of a mRNA HIV vaccine antigen, mRNA-1644, in Rwanda and South Africa.
Source: clinicaltrialsarena.com